Leap Investments LP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 84 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Leap Investments LP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$159,000
+10.4%
10,700
-21.4%
0.08%
-61.3%
Q2 2019$144,00013,6180.19%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 595,238$4,845,0003.97%
P.A.W. CAPITAL CORP 360,000$2,930,0003.19%
Telemetry Investments, L.L.C. 124,320$1,012,0002.20%
Soleus Capital Management, L.P. 472,558$3,847,0002.04%
Copernicus Capital Management, LLC 238,151$1,939,0001.85%
INTERWEST VENTURE MANAGEMENT CO 764,918$6,226,0001.80%
Trellus Management Company, LLC 200,000$1,628,0001.67%
683 Capital Management, LLC 2,622,914$21,350,0001.56%
KNOTT DAVID M 275,348$2,241,0001.32%
MANGROVE PARTNERS IM, LLC 1,092,394$8,892,0001.12%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders